Chuck Ence insider trades: Relmada Therapeutics (RLMD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Chuck reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | RLMD | ↑ Buy | 136,000 | $2.20 | $299K | Direct | Nov 6, 2025 (1d) |
| May 16, 2025 | RLMD | ↑ Buy | 228,961 | $0.45 | $103K | Direct | May 20, 2025 (4d) |
| Jan 31, 2024 | RLMD | ↑ Buy | 38,970 | $3.87 | $151K | Direct | Jan 31, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RLMD insiders
Open-market trades in the last 12 months
About Chuck Ence's insider trades
Chuck Ence is CA and CO at Relmada Therapeutics (RLMD). Since Jan 31, 2024, Chuck has reported 3 open-market purchases worth $553K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.